Axcella Reports Second Quarter Financial Results and Provides Business Update
CAMBRIDGE, Mass., August 03, 2023--(BUSINESS WIRE)--Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex...